# OnCo record cbi-1214 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cbi-1214/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cbi-1214" ;
  schema:name "CBI-1214"@en ;
  schema:description "CBI-1214 is an experimental bispecific T cell engager from Cartography Biosciences, in phase 1 trials for microsatellite-stable or MSI-low metastatic colorectal cancer."@en ;
  schema:url <https://onco.cc/drugs/cbi-1214/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07321106>, <https://clinicaltrials.gov/search?intr=CBI-1214> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Bispecific T cell engager" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:targets <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/cartography-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct07321106/> .